Cell & Gene Therapy Insights’ Post

How to build an #AAVplatform that produces higher titers and percent full #capsids Next month, join Leisha Kopp (Senior Field Applications Scientist, Mirus Bio) and Chris Brown (Senior Scientist of Process Development, ReciBioPharm) as they explore a #transfectionreagent and enhancer platform that increases both #AAVtiters and percent full capsids by 2- to 10-fold over existing technologies, regardless of #serotype, media choice, or suspension #HEKcell type. Attend to learn about: • Increasing both AAV titers and percent full capsids by 2- to 10-fold over existing technologies, regardless of serotype, media choice, or suspension HEK cell type • Case study data highlighting how a novel platform achieves high titers and percent full capsids without sacrificing efficiency • How to reduce cost per bioreactor run, and ultimately drive down cost per patient dose Register for this upcoming #webinar below:

Online Event

Online Event

To view or add a comment, sign in

Explore topics